BRPI0417950A - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number
BRPI0417950A
BRPI0417950A BRPI0417950-1A BRPI0417950A BRPI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A BR PI0417950 A BRPI0417950 A BR PI0417950A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
antagonists
relates
present
pharmaceutical
Prior art date
Application number
BRPI0417950-1A
Other languages
English (en)
Inventor
Mengwei Hu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0417950A publication Critical patent/BRPI0417950A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"COMPOSIçõES FARMACêUTICAS". A presente invenção refere-se a composições farmacêuticas compreendendo antagonistas de NK~ 1~.
BRPI0417950-1A 2003-12-22 2004-12-20 composições farmacêuticas BRPI0417950A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53173503P 2003-12-22 2003-12-22
US2004072893 2004-12-20

Publications (1)

Publication Number Publication Date
BRPI0417950A true BRPI0417950A (pt) 2007-04-17

Family

ID=34738689

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417950-1A BRPI0417950A (pt) 2003-12-22 2004-12-20 composições farmacêuticas

Country Status (16)

Country Link
US (1) US20050153999A1 (pt)
EP (1) EP1706116A1 (pt)
JP (1) JP2007515425A (pt)
KR (1) KR20060113737A (pt)
CN (1) CN1897942A (pt)
AR (1) AR046769A1 (pt)
AU (1) AU2004308935A1 (pt)
BR (1) BRPI0417950A (pt)
CA (1) CA2550432A1 (pt)
MX (1) MXPA06007210A (pt)
NO (1) NO20063393L (pt)
PE (1) PE20051049A1 (pt)
PL (1) PL380482A1 (pt)
TW (1) TW200531686A (pt)
WO (1) WO2005063243A1 (pt)
ZA (1) ZA200605080B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114922A2 (en) * 2006-04-05 2007-10-11 Schering Corporation Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
EP2004148B1 (en) * 2006-04-05 2015-07-15 OPKO Health, Inc. Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
PE20081891A1 (es) * 2007-03-22 2008-12-27 Opko Health Inc Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas
AR066191A1 (es) * 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
CA2743584A1 (en) * 2008-11-23 2010-05-27 Pfizer Inc. Lactams as beta secretase inhibitors
AU2014271269B2 (en) * 2009-08-14 2016-11-03 Opko Health, Inc. Intravenous formulations of neurokinin-1 antagonists
CN105503870A (zh) * 2009-08-14 2016-04-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
CN112472814A (zh) * 2012-01-23 2021-03-12 萨奇治疗股份有限公司 神经活性类固醇制剂和治疗中枢神经***障碍的方法
NL2018041B1 (en) * 2016-12-22 2018-06-28 Land Life Company B V Process to prepare a biodegradable pulp product
CA3140046A1 (en) * 2019-05-15 2020-11-19 Bexson Biomedical, Inc. Ketamine formulation for subcutaneous injection
CN113905735B (zh) * 2019-06-28 2024-03-15 福建盛迪医药有限公司 神经激肽-1拮抗剂
BR112022018876A2 (pt) 2020-04-03 2022-11-22 Nerre Therapeutics Ltd Antagonista de receptor de nk-1 para tratar uma doença selecionada a partir de sepse, choque séptico, síndrome de desconforto respiratório agudo (ards) ou síndrome de disfunção múltipla dos órgãos
CA3177477A1 (en) 2020-06-02 2021-12-09 Nerre Therapeutics Limited Neurokinin (nk)-1 receptor antagonists for use in the treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs
US20240016822A1 (en) * 2020-12-25 2024-01-18 Shanghai Shengdi Pharmaceutical Co., Ltd. Use of nk1 antagonist prodrug compound in combination with 5-ht3 receptor antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791346B3 (fr) * 1999-03-25 2001-04-27 Sanofi Sa Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
US20030055023A1 (en) * 2001-03-20 2003-03-20 Rajewski Roger A. Formulations containing etomidate and a sulfoalkyl ether cyclodextrin
PE20030762A1 (es) * 2001-12-18 2003-09-05 Schering Corp Compuestos heterociclicos como antagonistas nk1

Also Published As

Publication number Publication date
US20050153999A1 (en) 2005-07-14
MXPA06007210A (es) 2006-08-18
WO2005063243A1 (en) 2005-07-14
EP1706116A1 (en) 2006-10-04
PE20051049A1 (es) 2006-01-03
CN1897942A (zh) 2007-01-17
TW200531686A (en) 2005-10-01
KR20060113737A (ko) 2006-11-02
PL380482A1 (pl) 2007-02-05
JP2007515425A (ja) 2007-06-14
ZA200605080B (en) 2008-06-25
AU2004308935A1 (en) 2005-07-14
NO20063393L (no) 2006-07-21
CA2550432A1 (en) 2005-07-14
AR046769A1 (es) 2005-12-21

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
DE60311307D1 (de) Shampoo-zusammensetzungen
BRPI0417950A (pt) composições farmacêuticas
MEP10209A (en) Stable emulsion composition
GB2391473B (en) Pharmaceutical compositions
MX2007006241A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion.
IS7051A (is) Lyfjasamsetningar
DE602004018512D1 (de) Stifte zusammensetzungen
NO20063293L (no) Farmasoytiske forbindelser
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
DE60316954D1 (de) Shampoozusammensetzungen
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
BRPI0408446A (pt) tablete de limpeza
GB0213481D0 (en) Pharmaceutical compositions
BRPI0411820A (pt) composição farmacêutica
HU0304095D0 (en) Novel, effective pharmaceutical compositions
FR2887541B1 (fr) Compositions d'inertage d'impuretes
ITRE20040074A1 (it) "profumatore per ambienti"
BRPI0410638A (pt) derivados de azitromicina

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]